Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
This case report illustrates the successful use of activated recombinant factor VIIa in the management of severe postpartum hemorrhage secondary to amniotic fluid embolism.
Lim
Y
Y
Department of Anesthesia, KK Women's and Children's Hospital, Singapore 229899, Singapore. yvel6@hotmail.com
Loo
C C
CC
Chia
V
V
Fun
W
W
D000328:Adult; D002585:Cesarean Section; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000188:drug therapy*; D004619:Embolism, Amniotic Fluid / Q000150:complications / Q000188:drug therapy*; D005167:Factor VII / Q000008:administration & dosage / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D006473:Postpartum Hemorrhage / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa